Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading kidney disease, clinically associated with proteinuria and progressive renal failure. The occurrence of this disease is partly related to gene mutations. We describe a single affected family member who presented with FSGS. We used high-throughput sequencing, sanger sequencing to identify the pathogenic mutations, and a systems genetics analysis in the BXD mice was conducted to explore the genetic regulatory mechanisms of pathogenic genes in the development of FSGS. We identified high urinary protein (++++) and creatinine levels (149 μmol/L) in a 29-year-old male diagnosed with a 5-year history of grade 2 hypertension. Histopathology of the kidney biopsy showed stromal hyperplasia at the glomerular segmental sclerosis and endothelial cell vacuolation degeneration. Whole-exome sequencing followed by Sanger sequencing revealed a heterozygous missense mutation (c.643C > T) in exon 2 of TRPC6, leading to the substitution of arginine with tryptophan at position 215 (p.Arg215Trp). Systems genetics analysis of the 53 BXD mice kidney transcriptomes identified Pygm as the upstream regulator of Trpc6. Those two genes are jointly involved in the regulation of FSGS mainly via Wnt and Hippo signaling pathways. We present a novel variant in the TRPC6 gene that causes FSGS. Moreover, our data suggested TRPC6 works with PYGM, as well as Wnt and Hippo signaling pathways to regulate renal function, which could guide future clinical prevention and targeted treatment for FSGS outcomes.
Similar content being viewed by others
Data Availability
Not applicable.
References
Ashbrook DG et al (2021) A platform for experimental precision medicine: the extended BXD mouse family. Cell Syst 12(3):235–247
Bahcall OG (2015) Genetic testing ACMG guides on the interpretation of sequence variants. Nat Rev Genet 16(5):256
Buscher AK et al (2010) Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5(11):2075–2084
Buscher AK et al (2012) Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin Nephrol 78(1):47–53
Caster DJ et al (2022) Efficacy and safety of immunosuppressive therapy in primary focal segmental glomerulosclerosis: a systematic review and meta-analysis. Kidney Med 4(8):100501
Chen YM, Liapis H (2015) Focal segmental glomerulosclerosis: molecular genetics and targeted therapies. BMC Nephrol 16:1–10
Dryer SE, Reiser J (2010) TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol 299(4):F689–F701
Filler G et al (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42(6):1107–1113
Gallon L et al (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366(17):1648–1649
Gigante M et al (2011) TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype. Clin J Am Soc Nephrol 6(7):1626–1634
Glassock RJ (1996) Primary glomerular diseases. The kidney
Hanafusa H et al (2021) Heterozygous missense variant in TRPC6 in a boy with rapidly progressive infantile nephrotic syndrome associated with diffuse mesangial sclerosis. Am J Med Genet A 185(7):2175–2179
He X et al (2023) Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol 88:187–200
Heeringa SF et al (2009) A novel TRPC6 mutation that causes childhood FSGS. PLoS ONE 4(11):e7771
Hofstra JM et al (2013) New TRPC6 gain-of-function mutation in a non-consanguineous Dutch family with late-onset focal segmental glomerulosclerosis. Nephrol Dial Transplant 28(7):1830–1838
Junli H et al (2018) 5-HT promotes pulmonary arterial smooth muscle cell proliferation through the TRPC channel. Cell Mol Biol 64(13):89–96
Kaliounji A et al (2021) A life-changing diagnosis of focal segmental glomerulosclerosis in a young hispanic male. Cureus 13(12):e20323
Karimi Yazdi A et al (2018) The first successful application of preimplantation genetic diagnosis for hearing loss in Iran. Cell Mol Biol 64(9):1718
Köhler S et al (2017) The human phenotype ontology in 2017. Nucleic Acids Res 45(D1):D865–D876
Lee H et al (2014) Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312(18):1880–1887
Lepori N et al (2018) Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J 11(2):179–190
Liao Y et al (2019) WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res 47(W1):W199–W205
Liu BC et al (2013) High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. BBA-Mol Cell Res 1833(6):1434–1442
Llavero F et al (2019) McArdle disease: new insights into its underlying molecular mechanisms. Int J Mol Sci 20(23):5919
McKenna A et al (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297–1303
Meliambro K et al (2017) The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. J Biol Chem 292(51):21137–21148
Mir S et al (2012) TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27(1):205–209
Mukerji N, Damodaran TV, Winn MP (2007) TRPC6 and FSGS: the latest TRP channelopathy. Biochem Biophys Acta 1772(8):859–868
Mulligan MK et al (2017) GeneNetwork: a toolbox for systems genetics. Syst Genet 75–120
Nogales-Gadea G et al (2012) Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain 135(7):2048–2057
Nogales-Gadea G et al (2015) McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat 36(7):669–678
Paster SB, Adams DF, Hollenberg NK (1975) Acute renal failure in McArdle’s disease and myoglobinuric states. Radiology 114(3):567–570
Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83(1):253–307
Pfeffer CM, Ho BN, Singh ATK (2017) The evolution, functions and applications of the breast cancer genes BRCA1 and BRCA2. Cancer Genomics Proteomics 14(5):293–298
Riehle M et al (2016) TRPC6 G757D loss-of-function mutation associates with FSGS. J Am Soc Nephrol 27(9):2771–2783
Rosenberg AZ, Kopp JB (2017) Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 12(3):502–517
Santin S et al (2009) TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant 24(10):3089–3096
Schlöndorff J et al (2009) TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol Cell Physiol 296(3):C558–C569
Shabaka A, Ribera AT, Fernández-Juárez G (2020) Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective. Nephron 144(9):413–427
Shkreli M et al (2012) Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med 18(1):111–119
Sunohara M et al (2019) Upregulation of tumor susceptibility gene 101 (TSG101) by mechanical stress in podocytes. Cell Mol Biol 65(1):84–88
Uffelmann E et al (2021) Genome-wide association studies. Nat Rev Methods Primers 1(1):59
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164–e164
Wang B et al (2023) Identification of key biomarkers in hepatocellular carcinoma induced by non-alcoholic steatohepatitis or metabolic syndrome via integrated bioinformatics analysis: biomarkers in NASH-induced hepatocellular carcinoma. Cell Mol Biol 69(7):174–180
Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71(12):1205–1214
Winn MP et al (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308(5729):1801–1804
Wolf G, Chen SD, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease—podocyte injury comes of age in diabetic nephropathy. Diabetes 54(6):1626–1634
Woroniecka KI et al (2011) Transcriptome analysis of human diabetic kidney disease. Diabetes 60(9):2354–2369
Xiao S-Y et al (2019) Identification of a novel missense eya4 mutation causing autosomal dominant non"‘syndromic hearing loss in a chinese family. Cell Mol Biol 65(3):84–88
Xie JY, Chen N (2013) Primary glomerulonephritis in mainland China: an overview. In: Chen N (ed) New insights into glomerulonephritis: pathogenesis and treatment, pp 1–11
Yang X et al (2015) miR-135 family members mediate podocyte injury through the activation of Wnt/beta-catenin signaling. Int J Mol Med 36(3):669–677
Zhu B et al (2009) Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res-Fundam Mol Mech Mutagenesis 664(1–2):84–90
Zhuang Q et al (2021) Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis. Lab Invest 101(2):258–270
Zúñiga-García V et al (2015) Differential expression of ion channels and transporters during hepatocellular carcinoma development. Dig Dis Sci 60:2373–2383
Funding
This research was funded by the Binzhou Medical University Research Start-up Fund (50012304486) to FX and the Taishan Scholar Program (No. Tsqn202103198) to CL.
Author information
Authors and Affiliations
Contributions
Data analysis: YJ, XC, NL, and SW; Funding acquisition: FX and CL; Methodology: TY, FX, and WW; Supervision: CL and YZ; Visualization: CX, YL, and HT; Information collection: YX and HZ; Writing—original draft: TY and YJ; Writing—review & editing: FX, YZ, NK, and KU.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical Approval
Yantai Yuhuangding Hospital Ethics Committee approved the study protocol.
Consent to Participate
Patient consent was obtained.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yu, T., Ji, Y., Cui, X. et al. Novel Pathogenic Mutation of P209L in TRPC6 Gene Causes Adult Focal Segmental Glomerulosclerosis. Biochem Genet (2024). https://doi.org/10.1007/s10528-023-10651-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-023-10651-y